$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
福替沙韦(Fostemsavir)的副作用和不良反应
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)中文说明书
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)的用法用量:用药指南,剂量调整,特殊人群用药
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的用药注意事项
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)是治疗什么疾病的
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的副作用如何缓解
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的功效与作用
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的详细说明书:作用与功效,用法用量,副作用,注意事项等
2025-10-19 11:44:20
Check Details
FDA批准Cabenuva和卡替拉韦(Vocabria)用于HIV治疗:Cabenuva为首个完整长效注射方案,卡替拉韦为口服疗法
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的注意事项和药物相互作用
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的副作用和不良反应
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)中文说明书
2025-10-19 11:44:20
Check Details
1
2
...
3993
3994
3995
3996
3997
3998
3999
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Urece® (Dotinurad): A Breakthrough in Gout and Hyperuricemia Management
2
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
3
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
4
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
5
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
6
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
7
A Precision FGFR Inhibitor for Cholangiocarcinoma
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial